Progress in the treatment of uveitis
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

National Natural Science Foundation of China(No.81770948); Fujian Provincial Science and Technology Innovation Leadership Talent Foundation(No.2016B011)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The uveitis is a clinical common involving the iris, ciliary body, vitreous body, choroid, retina and retinal blood vessels, a group of inflammatory disease causes complex, due to the pathogenesis of uveitis did not clarify clearly, looking for effective treatment of uveitis drugs has been the main direction of ophthalmic research, in addition to the traditional glucocorticoid, cycloplegia agent, nonsteroidal anti-inflammatory drugs(nsaids), immune inhibitor has a good curative effect on uveitis, along with the development of molecular biology, a new type of biological agents, gene therapy, could fairly claim a place in the history of Chinese medicine in the treatment of uveitis. This article aims to review the latest progress in the treatment of uveitis.

    Reference
    Related
    Cited by
Get Citation

Xing-Xing Liao, Guo-Xing Xu. Progress in the treatment of uveitis. Guoji Yanke Zazhi( Int Eye Sci) 2020;20(4):631-634

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:May 16,2019
  • Revised:February 27,2020
  • Adopted:
  • Online: March 25,2020
  • Published: